Could Positive Results on a COVID Anitbody Drug Be Just What the Markets Need?
Markets were under pressure Tuesday on renewed fears about the spread of the coronavirus, but could late-breaking news out of a Regeneron trial turn things around? Plus, after-hours earning action in shares of Micron, and will it be a happy holiday season for retailers?
You May Also Like
Le Podcast de Pauline Laigneau
Pauline Laigneau
Shares for Beginners
Philip Muscatello - Australian Investor Education
Talking Billions with Bogumil Baranowski
Bogumil Baranowski
On the Way to New Work - Der Podcast über neue Arbeit
Christoph Magnussen & Michael Trautmann
就是愛玩股
玩股網
7 Minute Leadership
Paul Falavolito
One Rental At A Time
Michael Zuber
Proactive - Interviews for investors
Proactive
The POZCAST: Decoding Success with Adam Posner
NHP Talent Group, Adam Posner
손에 잡히는 경제
MBC
Le Podcast de Pauline Laigneau
Pauline Laigneau
Shares for Beginners
Philip Muscatello - Australian Investor Education
Talking Billions with Bogumil Baranowski
Bogumil Baranowski
On the Way to New Work - Der Podcast über neue Arbeit
Christoph Magnussen & Michael Trautmann
就是愛玩股
玩股網
7 Minute Leadership
Paul Falavolito
One Rental At A Time
Michael Zuber
Proactive - Interviews for investors
Proactive
The POZCAST: Decoding Success with Adam Posner
NHP Talent Group, Adam Posner
손에 잡히는 경제
MBC
Community discussion